NCT06778954Recruiting
Ropivacaine-Poloxamer 407 Gel for Pain Control After Open Gastrectomy
Prospective Randomized Controlled Trial of Ropivacaine-Poloxamer 407 Based Gel Application on Postoperative Pain After Open Gastrectomy
Source: ClinicalTrials.gov · Last updated 14 Feb 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The study evaluates the efficacy of Ropivacaine-Poloxamer 407 hydrogel in reducing postoperative pain following open gastrectomy.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 48 (estimated)
- First submitted
- 5 Jan 2025
- Start date
- 30 Jan 2025
- Primary completion date
- 1 Nov 2025
- Lead sponsor
- Gangnam Severance Hospital
- Diseases
- Gastric and esophageal cancer
- NCT number
- NCT06778954
What you commit to
- Study type: Interventional
- Planned participants: 48
- From 30 Jan 2025 to the primary completion date, 1 Nov 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients who have undergone preoperative chemotherapy or radiotherapy.
Other illness
- Diagnosis of malignancies other than gastric cancer.
- Uncontrolled diabetes, autoimmune diseases, hypertrophic scars, or keloid history affecting wound healing.
- History of allergy or adverse reactions to Ropivacaine or other local anesthetics.
- Patients with preoperative chronic pain conditions, including CRPS.
- Patients with psychiatric disorders deemed likely to interfere with study participation.
- Patients with severe liver disease, renal disease, or arrhythmia.
Age
- Patients under 19 years of age.
Other
- Presence of ascites or peritoneal metastasis.
- Pregnant women.
- Patients with long-term preoperative use of opioid analgesics.
Who the study is looking for
- Patients with a histologically confirmed diagnosis of gastric adenocarcinoma prior to surgery.
- Patients who have undergone a complete surgical resection (R0 resection).
- Patients with an ASA (American Society of Anesthesiologists) score of 3 or below.
- Patients aged 20 years or older.
Age in the registry: 20 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| GangnamSeverance Hospital Coordinator of this site? Confirm its status | Seoul | South Korea | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.